Home > Insider Trading > Filing (0000899243-20-025917)

Filing Details

Accession Number:: 0000899243-20-025917
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-09-22 16:15:26
Reporting Period:: 2020-09-18

Accepted Time:: 2020-09-22 16:15:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1261333	Docusign Inc.	DOCU	Services-Prepackaged Software (7372)	912183967

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1295402	T Enrique Salem	C/O Bain Capital Venture Investors, Llc 200 Clarendon Street Boston MA 02116		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-09-18	5,808	$188.87	1,368,491	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2020-09-18	9,616	$189.80	1,358,875	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2020-09-18	8,263	$190.71	1,350,612	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2020-09-18	7,300	$191.72	1,343,312	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2020-09-18	4,897	$192.67	1,338,415	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2020-09-18	1,700	$193.77	1,336,715	No	4	S	Indirect	See Footnotes
Common Stock	Disposition	2020-09-18	11,715	$194.97	1,325,000	No	4	S	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes
No	4	S	Indirect	See Footnotes

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	166,093	Direct

Footnotes

Represents shares of Common Stock held directly by BCIP Venture Associates ("BCIP Venture"), BCIP Venture Associates-B ("BCIP Venture-B"), BCIP Venture Associates II, L.P. ("BCIP Venture II"), BCIP Venture Associates II-B, L.P. ("BCIP Venture II-B"), Bain Capital Venture Fund 2014, L.P. ("Venture Fund 2014"), Bain Capital Venture Partners 2014, L.P. ("Venture Partners 2014"), Bain Capital Venture Coinvestment Fund, L.P. ("Coinvestment Fund") and Bain Capital Venture Coinvestment Partners, L.P. ("Coinvestment Partners" and, collectively, the "Bain Venture Entities").
Bain Capital Venture Investors, LLC ("BCVI") is (i) the general partner of Venture Partners 2014 and Coinvestment Partners, (ii) the ultimate general partner of Venture Fund 2014 and Coinvestment Fund and (iii) governs the investment strategy and decision making process with respect to investments held by each of BCIP Venture, BCIP Venture-B, BCIP Venture II and BCIP Venture II-B. Mr. Salem is a member of the Executive Committee and a Managing Director of BCVI. By virtue of the relationships described in this footnote, Mr. Salem may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Venture Entities. Mr. Salem disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.22 to $189.18, inclusive. The reporting person undertakes to provide to DocuSign, Inc., any security holder of DocuSign, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (9) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.24 to $190.22, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.25 to $191.24, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.27 to $192.25, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.28 to $193.15, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.31 to $194.06, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.50 to $195.25, inclusive.